Clinical Trials Browser

Abdominal Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms, Urogenital Neoplasms, Vulvar Diseases, Vulvar Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Epstein-Barr Virus Infections, Papillomavirus Infections, Microsatellite Instability, Small Cell Lung Carcinoma

NCT05388773 2025-06-19

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Phase 2 Recruiting

150 enrolled

Head & Neck

Carcinoma, Squamous Cell, DNA Virus Infections, Head and Neck Neoplasms, Stomatognathic Diseases, Neoplasms, Glandular and Epithelial, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Papilloma, Pharyngeal Diseases, Pharyngeal Neoplasms, Tumor Virus Infections, Papillomavirus Infections

NCT06793410 2025-06-05

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Phase 2 Recruiting

100 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Papillomavirus Infections

NCT06052033 2025-05-13

Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection

Phase NA Recruiting

40 enrolled

Gynecologic

Squamous Intraepithelial Lesions, Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

250 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT05829629 2025-02-14

Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women

Phase 1 Recruiting

20 enrolled

Papillomavirus Infections

NCT06686043 2024-11-13

HPV-VIM

Phase 2 Recruiting

85 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Papillomavirus Infections

NCT06416150 2024-10-26

Reducing Urban Cervical Cancer Disparities

Phase NA Recruiting

546 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05336240 2024-08-26

PCOM2

Phase NA Recruiting

120 enrolled

Papillomavirus Infections

NCT06467942 2024-06-21

ELIMVLHPV

Phase NA Recruiting

240 enrolled

Papillomavirus Infections

NCT06326294 2024-05-22

Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

Phase NA Recruiting

4,844 enrolled

HIV Infections, Papillomavirus Infections

NCT06371118 2024-05-14

HERSELF

Phase NA Recruiting

1,000 enrolled

Gynecologic

Uterine Cervical Neoplasms, Self-Examination, Papillomavirus Infections

NCT05860725 2024-05-09

Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

Phase NA Recruiting

220 enrolled

Vaccination Hesitancy, Papillomavirus Infections

NCT04895020 2024-04-17

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Phase 3 Recruiting

1,200 enrolled

Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05027776 2024-04-17

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Phase 3 Recruiting

1,348 enrolled

Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Papillomavirus Infections

NCT05625633 2024-04-05

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Phase 2/3 Recruiting

120 enrolled

Warts, Papillomavirus Infections

NCT04910802 2021-09-16

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

Phase 4 Recruiting

150,000 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Clinical Trials

CASCADE3001A

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

LMI-001-A-S04

Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

(NeoScorch HN)

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

KOPRETINA

POC

(HPV)

(iSTAR)

RIFT-HPV

ASHA-Health II

Effect of Different HPV Education Methods on Vaccination Intention in Young Women

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

EQUIP

HPV-Education

A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

PopSci CHW4CervixHealth

Pocket Colposcopy Using CARE Algorithm

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Zopa Retreatment and Vector Shedding in Adults With RRP

Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years

a-HPVVIH

HPVsign

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

ART-CIN_IIB

HPV videos

ART-VIN IIB

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

START-001

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection

AGO-Gard

Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women

HPV-VIM

Reducing Urban Cervical Cancer Disparities

PCOM2

ELIMVLHPV

Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

HERSELF

Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden